Please login to the form below

Not currently logged in
Email:
Password:

BMS appoints Murdo Gordon as chief commercial officer

He also becomes executive vice president

BMS Murdo GordonBristol-Myers Squibb has appointed Murdo Gordon to the newly-created position of executive vice president and chief commercial officer.

In this new role, Gordon will have responsibility for the New York-headquartered firm's global commercial strategy, as well as its new worldwide commercialisation team. He will report directly to BMS' chief executive Giovanni Caforio.

Gordon has nearly 30 years of industry experience with the biopharma company, having first joined its Canadian operations in 1989, where he held positions of increasing responsibility, including vice president of marketing, before moving to the US in 2003.

There he worked in a number of senior commercial leadership posts across the cardiovascular and neuroscience therapeutic areas, as well as in market access.

He was promoted to president of BMS' US operations in 2013, before taking on his most recent role as head of worldwide markets in January last year.

Gordon currently also serves a member of the board of directors for RWJBarnabas Health, a New Jersey-based comprehensive healthcare services provider.

22nd June 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics